Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Apr 6, 2010


Steve Lincoln has joined Complete Genomics as vice president of scientific applications. Lincoln previously served as vice president of informatics at Affymetrix, executive vice president of product development and chief scientific officer of InforMax, and vice president of bioinformatics R&D at Incyte.

WaferGen Biosystems has named Janet Lankard as senior vice president of worldwide sales.

Lankard joins WaferGen from VisEn Medical, where she served as vice president of sales and technical collaborations. She also held sales positions at Applied Biosystems, now Life Technologies; Affymetrix; and Quantum Dot.

Lankard holds a BS in biochemistry from California Polytechnic University.

Asuragen has appointed Lyle Arnold to serve on its board of directors. Arnold previously was vice president of research at Gen-Probe, where he also was head of technology research in the late 1980s. He has worked in senior management and scientific positions at Molecular Biosystems, Genta, Synteni, Incyte Genomics, and Oasis Bioscience.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.